Amarantus Bioscience Holdings Inc (AMBS)

[dubbya]

Hard to say since every time I turn around they issue more shares well before they said they would, but this is my guess:

1) The release of good news on LymPro and/or announce a licensing deal for it will begin the process and should drive the share price over .10 which will trigger more dilution later (~173m).

2) Soon after positive news they will do a reverse split of maybe 1:25, so if there are 700m shares OS at that point, it would bring it down to about 28m shares. I'm not concerned about a RS, since it's basically revaluing shares by adjusting the shares OS, but the big plus is that it will enable an uplisting.
Dilution is another story.

3) At that point they will issue more shares. I expect 20% dilution, which would be another 5.6m shares. With 173m shares coming around that same time due to the .10 price being tripped, I would not expect more than 20%. Needless to say, I would not be buying until after this last stage is completed and the share price has had time to settle down.

Just my personal opinion.